Company intelligence / Profile preview

Gemseki

Ownership: Private
Development stage: Other

Overview

As an open innovation and licensing platform subsidiary of SNBL in Japan, Gemseki connects licensors and licensees globally to facilitate out-/in-license deals for drug candidates and technologies across all development stages. No clinical results are attributed to the company itself as it does not develop drugs internally.

Therapeutic areas: Other
Modalities: Not directly applicable; facilitates licensing for a wide range of modalities including Small moleculeMonoclonal antibodyGene therapyetc. (as per marketplace scope)
Industry: Drug Discovery Services

Partnerships

Partners with global biotech/pharma companies and academic institutions seeking or offering licenses; no specific names disclosed publicly.

Beyond the preview

Go deeper on Gemseki.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gemseki.

Explore the full profile